Systemic immune system alterations in early stages of Alzheimer's disease.
about
Nutrients, Microglia Aging, and Brain AgingNeuroinflammation in Alzheimer's disease: chemokines produced by astrocytes and chemokine receptorsA deficiency in CCR2+ monocytes: the hidden side of Alzheimer's diseaseArginine deprivation and immune suppression in a mouse model of Alzheimer's diseaseAnti-Viral Properties of Amyloid-β Peptides.Reduced cerebrospinal fluid concentration of interleukin-12/23 subunit p40 in patients with cognitive impairment.Chronic intermittent hypoxia induces oxidative stress and inflammation in brain regions associated with early-stage neurodegeneration.A Novel Method to Identify Differential Pathways in Hippocampus Alzheimer's DiseasePerioperative frailtyPossible protective role of the 489C>T P2X7R polymorphism in Alzheimer's disease.Effects of storage conditions on the stability of serum CD163, NGAL, HMGB1 and MIP2Myeloid dendritic cells are decreased in peripheral blood of Alzheimer's disease patients in association with disease progression and severity of depressive symptoms.Serum IL-8 is a marker of white-matter hyperintensities in patients with Alzheimer's disease.Role of neuroinflammation in neurodegeneration: new insightsThe Potential Role of Chemokines in Alzheimer's Disease Pathogenesis.Chronic functional bowel syndrome enhances gut-brain axis dysfunction, neuroinflammation, cognitive impairment, and vulnerability to dementia.The dynamics of monocytes and microglia in Alzheimer's disease.Proteome characterization of splenocytes from an Aβpp/ps-1 Alzheimer's disease model."Boomerang Neuropathology" of Late-Onset Alzheimer's Disease is Shrouded in Harmful "BDDS": Breathing, Diet, Drinking, and Sleep During Aging.Relationships Between Mitochondria and Neuroinflammation: Implications for Alzheimer's Disease.Protective Effect of Amyloid-β Peptides Against Herpes Simplex Virus-1 Infection in a Neuronal Cell Culture Model.Common neurodegenerative pathways in obesity, diabetes, and Alzheimer's disease.Glial biomarkers in human central nervous system disease.Clearance of cerebral Aβ in Alzheimer's disease: reassessing the role of microglia and monocytes.Extensive Association of Common Disease Variants with Regulatory Sequence.Identification of oxidative modifications of hemopexin and their predicted physiological relevance.Comparative profiling of cortical gene expression in Alzheimer's disease patients and mouse models demonstrates a link between amyloidosis and neuroinflammation.Plasma MCP-1 and Cognitive Decline in Patients with Alzheimer's Disease and Mild Cognitive Impairment: A Two-year Follow-up Study.Serum Protein-Based Profiles as Novel Biomarkers for the Diagnosis of Alzheimer's Disease.SB203580 reverses memory deficits and depression-like behavior induced by microinjection of Aβ1-42 into hippocampus of mice.Paeoniflorin Atttenuates Amyloidogenesis and the Inflammatory Responses in a Transgenic Mouse Model of Alzheimer's Disease.MCP-1 and CCR2 gene polymorphisms in Parkinson's disease in a Han Chinese cohort.Mutual effect of cerebral amyloid β and peripheral lymphocytes in cognitively normal older individuals.Methylglyoxal-bis-guanylhydrazone inhibits osteopontin expression and differentiation in cultured human monocytes.gene variation and microglial activity on [C]PBR28 PET in older adults at risk for Alzheimer's disease
P2860
Q26768461-ADF5FF96-F25B-492B-9C55-36C6016014D4Q26995483-9B70033C-D19A-4503-9262-9D195BFCC5C9Q26997058-51ECE296-5D4E-4FD9-8304-EDDA1FC1672BQ28391826-B3F7E29E-2467-4536-A3C2-A462AE5A4DEAQ30390299-6BCBF5AA-CB64-47F7-813D-E80ADE700B69Q33626656-1B8061B5-D2A0-4F3B-97FF-BEA9F268BFBBQ33679761-E14C637F-D3A1-45BF-97A1-A05E571894F4Q33702839-7C106389-42C7-405F-A2D1-7DAD3D676DB1Q34278764-BA1AF313-4AA2-4C12-8FF0-9F9FC582F80FQ34702157-CB3E0A09-86C3-45E9-BF0B-E27B9D52B888Q35741156-7AAC61D3-1856-4388-B1A0-22BC835A78C3Q36503723-8163C595-0B1C-441F-B48A-29CC96977B0EQ37654102-4359ECB7-F87C-42CE-95E0-59DAD626CF1FQ37680099-02F84B46-F5EC-46F5-B6A0-A8ABF1CACED1Q38177234-CC9E775E-837A-4BFC-8A03-4276CA6B58DDQ38192977-8875BE26-31BF-4F2B-9EFC-1289D45181C4Q38423147-A8E4A26F-C304-4F97-A08D-0E53424025CDQ38440340-AC76017B-A58C-4A34-8E9C-44D97057A32BQ38441500-71FADBD6-063C-4F83-9F32-8F03758CA723Q38574670-8BDEF698-43B1-425D-867D-086A87DE2CA5Q38797410-3BF32CB0-5DEB-4862-A5B2-0C84B10BDAE1Q38828830-F25670B0-FD66-42F9-A503-D7391C7836EDQ38845041-BD6BF949-DE05-4C0C-972B-8406E9209ADCQ39135845-4B091419-4819-479E-A7DC-34D32C19880BQ40462197-80F3E8DA-79FD-44D2-B6C1-5B3AFA61F303Q46353874-BF68A276-AEFC-43AA-A8AE-05B4D802B562Q47105056-F033363F-6DED-485C-9645-6B6751E55E96Q47553904-A3D6DBCA-89C2-4B34-B877-CE0B97748948Q47822179-5E82BFDB-2533-45B9-99ED-398DFABCED73Q48046432-52A63F82-6834-4625-A373-A024CC0E9E4CQ48132377-A6DE82FC-1246-4ADC-9DA3-DE58330A939FQ48180975-122EA61A-7D91-44F3-93EC-C90E0FD158BDQ48325665-7CDFA884-CEAC-45DE-A3AB-28ABDEE6EF0EQ55256802-6DDA6191-7883-4FE6-95A2-899244623FA9Q56989585-589EA904-9D62-4EEF-ABA9-D3F8CDB6263E
P2860
Systemic immune system alterations in early stages of Alzheimer's disease.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Systemic immune system alterations in early stages of Alzheimer's disease.
@ast
Systemic immune system alterations in early stages of Alzheimer's disease.
@en
type
label
Systemic immune system alterations in early stages of Alzheimer's disease.
@ast
Systemic immune system alterations in early stages of Alzheimer's disease.
@en
prefLabel
Systemic immune system alterations in early stages of Alzheimer's disease.
@ast
Systemic immune system alterations in early stages of Alzheimer's disease.
@en
P2093
P2860
P1476
Systemic immune system alterations in early stages of Alzheimer's disease.
@en
P2093
Catherine Madison
Dallas A Forshew
Jonathan Katz
Michael S McGrath
Robert G Miller
Ronald Honrada
Rongzhen Zhang
Will Harris
P2860
P356
10.1016/J.JNEUROIM.2013.01.002
P577
2013-02-04T00:00:00Z